Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (365)	12/26/1998 11:02:00 AM
From: Ian@SI	Read Replies (1) \| Respond to of 1321

Financial post likes the FDA approval too... Saturday, December 26, 1998 QLT on the move again Stock up 39% in a week: Wider clearance for use of drug a boost for Vancouver firm By GARRY MARR The Financial Post QLT Phototherapeutics Ltd. (QLT/TSE), up 10¢ to $34, on volume of 81,268 shares. The company's stock was moving up again on Thursday, reaching as high $35 before falling off. On Wednesday, QLT said its Photofrin light-therapy drug had won wider clearance for use to help reduce pain and airway obstruction in lung cancer patients. The U.S. Food & Drug Administration had already given the go-ahead for the drug and laser light combination therapy to be used in treating early stage lung cancer tumours when other treatments, such as chemotherapy, are not feasible. The Vancouver-based company's stock rose as high as $36 on Wednesday, a 52-week intraday high. It has now gained 39% since closing at $24.50 on Dec. 16.